Literature DB >> 24345074

Epidemiology of active tuberculosis in lung cancer patients: a systematic review.

Antonis Christopoulos1, Muhammad W Saif, Evangelos G Sarris, Kostas N Syrigos.   

Abstract

OBJECTIVES: The aim of this review article is to evaluate the available literature concerning the prevalence of active tuberculosis in lung cancer patients. DATA SOURCE: MEDLINE, PubMed, EMBASE and Medscape databases were searched for studies with quantitative data on the interaction between tuberculosis (TB) and lung cancer, published since 1952. We used the Medical Subject Headings' term 'tuberculosis' and the text-word terms 'TB' and 'Mycobacterium infection', and also, the Medical Subject Headings' terms 'neoplasm' and 'lung neoplasm', or the text-word term 'lung cancer'. DATA SELECTION: We selected studies with cases verified by bacteriological examinations and biopsies that contained enough data to estimate tuberculosis prevalence. We did not exclude any study on the basis of language.
RESULTS: The prevalence of active tuberculosis among lung cancer patients varies depending on spatial and regional factors. Lung cancer patients who are more prone to developing tuberculosis are Asian and Caucasian males, with an average age of 60 years old. The prevalence of tuberculosis is higher in patients with chest X-ray evidence of old tuberculosis and/or history of tuberculosis, chronic obstructive pulmonary disease, heavy cigarette smoking, increased alcohol consumption, and/or diabetes mellitus. A high mortality rate because of tuberculosis in lung cancer patients was also estimated.
CONCLUSION: Active tuberculosis complicating lung cancer is a significant clinical issue in countries with high prevalence of tuberculosis. However, as the there is a lack of reports from developed countries over the last 20 years, the significance of this interaction in countries with low tuberculosis burden remains controversial.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  lung cancer; malignancy; mycobacterium infection; neoplasm; tuberculosis

Mesh:

Year:  2014        PMID: 24345074     DOI: 10.1111/crj.12094

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  12 in total

1.  Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis.

Authors:  Claudia C Dobler; Kelvin Cheung; John Nguyen; Andrew Martin
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

2.  Linking common non-coding RNAs of human lung cancer and M. tuberculosis.

Authors:  Debmalya Barh; Sandeep Tiwari; Ranjith N Kumavath; Preetam Ghosh; Vasco Azevedo
Journal:  Bioinformation       Date:  2018-06-30

3.  Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1/PDl-1 signaling pathway.

Authors:  Shuhui Cao; Jingwen Li; Jun Lu; Runbo Zhong; Hua Zhong
Journal:  Cell Death Dis       Date:  2019-01-18       Impact factor: 8.469

Review 4.  Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations.

Authors:  Amalia Anastasopoulou; Dimitrios C Ziogas; Michael Samarkos; John M Kirkwood; Helen Gogas
Journal:  J Immunother Cancer       Date:  2019-09-04       Impact factor: 13.751

Review 5.  Microbes in Tumoral In Situ Tissues and in Tumorigenesis.

Authors:  Xue Feng; Lu Han; Sijia Ma; Lanbo Zhao; Lei Wang; Kailu Zhang; Panyue Yin; Lin Guo; Wei Jing; Qiling Li
Journal:  Front Cell Infect Microbiol       Date:  2020-11-24       Impact factor: 5.293

6.  Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor.

Authors:  Yalin Xie; Ning Su; Wei Zhou; An Lei; Xiang Li; Weiwei Li; Zhan Huang; Wenchang Cen; Jinxing Hu
Journal:  Cancer Manag Res       Date:  2021-10-01       Impact factor: 3.989

7.  A case report of dermatomyositis with the missed diagnosis of non-small cell lung cancer and concurrence of pulmonary tuberculosis.

Authors:  Yuting Yin; Jing Chi; Yang Bai
Journal:  Open Med (Wars)       Date:  2022-03-04

8.  Evaluation of coexistence of cancer and active tuberculosis; 16 case series.

Authors:  Beyhan Çakar; Aydın Çiledağ
Journal:  Respir Med Case Rep       Date:  2017-11-20

9.  Inhibition of the Hedgehog Signaling Pathway Depresses the Cigarette Smoke-Induced Malignant Transformation of 16HBE Cells on a Microfluidic Chip.

Authors:  Yong-Xin Qin; Zhi-Hui Yang; Xiao-Hui Du; Hui Zhao; Yuan-Bin Liu; Zhe Guo; Qi Wang
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628

10.  Incidence of and Risk Factors for Tuberculosis among Cancer Patients in Endemic Area: A Regional Cohort Study.

Authors:  Sirinya Nanthanangkul; Supannee Promthet; Krittika Suwanrungruang; Chalongpon Santong; Patravoot Vatanasapt
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.